G2 Lab and Pathology Insider

Subscribe today for access to
Articles and Reports

Latest Articles

Philanthropy Giants Funding Medical Research

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Facebook founder Mark Zuckerberg grabbed headlines this week because of the letter he and his wife wrote to their newborn daughter announcing they will give 99 percent of their Facebook shares...

Cigna Becomes First Insurer to Cover Whole Exome Sequencing

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Cigna became the first national health insurance plan to publish a coverage policy on whole exome sequencing (WES). The insurer defined coverage criteria for WES, but still will not cover WGS for...

HHS’ Top Ten Management Problems Include Labs

By Kelly A. Briganti, Editorial Director, G2 Intelligence The OIG's FY 2015 Top Management and Performance Challenges target clinical laboratories among other providers as a necessary focus of efforts to fight fraud, abuse and waste in Medicare. Specifically, the...

Avellino Expands Gene Testing for LASIK Prep Test

By Ron Shinkman, Editor, Laboratory Industry Report California-based Avellino Labs has expanded its molecular testing menu for patients who are considering lasik or other elective surgeries that will alter the structure of their eyes. Elective laser eye surgery,...

Special Focus: The Rise of Liquid Biopsy Testing

From - Diagnostic Testing & Emerging Technologies
Early in the year DTET spoke to experts that predicted 2015 would be the year that liquid biopsy technology penetrates the clinical oncology market. These predictions did not disappoint. A near continuous stream of publications, conference presentations, and…

. . . read more